ORIGINAL RESEARCH article

Front. Endocrinol.

Sec. Thyroid Endocrinology

Volume 16 - 2025 | doi: 10.3389/fendo.2025.1582610

Iodine supplementation for pregnancy in Portugal: identification of nutritional composition and characterization of pharmacy dispenses from 2008-2022

Provisionally accepted
Sarai  Isabel MachadoSarai Isabel Machado1Susana  RoqueSusana Roque1Maria  Lopes-PereiraMaria Lopes-Pereira1,2Maria  José CosteiraMaria José Costeira1,3Patrício  CostaPatrício Costa1Nuno  BorgesNuno Borges4Ruben  PereiraRuben Pereira5Zilda  MendesZilda Mendes5Teixeira  AntónioTeixeira António5Joana  A PalhaJoana A Palha1*
  • 1Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal, Braga, Braga, Portugal
  • 2Hospital de Braga, Braga, Braga, Portugal
  • 3Hospital da Senhora da Oliveira Guimarães, Guimarães, Portugal
  • 4Faculty of Nutrition and Food Sciences, University of Porto, Porto, Portugal
  • 5Centre for Health Evaluation & Research of the National Association of Pharmacies (CEFAR-ANF), Lisboa, Portugal

The final, formatted version of the article will be published soon.

Background: Iodine is essential for the proper development of the central nervous system. In Portugal, despite of self-reports of iodine supplements intake by pregnant women, iodine deficiency still prevails.This study intended to characterize the pharmacy sales of iodine-containing supplements and their use by women in Portugal.Data from all available supplements with indication for use in the prenatal time, for the period 2008-2022, was obtained from the Portuguese Association of Pharmacies. To infer from the use of iodine supplements by women during preconception, pregnancy and lactation, pharmacy dispenses, between 2019 and 2021, were collected from a sample of female consumers, identified with at least one prescription.Results: Eighty-eight per cent of the iodine-containing supplements, state the recommended iodine concentration. The annual sales increased continuously, reaching an estimated of 109 µg per day in 2022. Estimated mean duration of supplementation to women prescribed with iodine-containing supplements for preconception/pregnancy/lactation was of 4.5 months (SD = 3.8) and less than 1% of women was covered for the advisable period of 18 months.The estimated duration of iodine supplementation to women during preconception, pregnancy and lactation is below recommendations. Additional public health measures, such as universal salt iodization and literacy campaigns are needed to ensure iodine sufficiency to women and their developing foetus.

Keywords: Pregnancy, Public Health, Iodine, iodine deficiency, supplementation

Received: 24 Feb 2025; Accepted: 01 May 2025.

Copyright: © 2025 Machado, Roque, Lopes-Pereira, Costeira, Costa, Borges, Pereira, Mendes, António and Palha. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Joana A Palha, Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal, Braga, Braga, Portugal

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.